The world is experiencing an epidemic of obesity and its concomitant health problems. One implication is that the normally robust negative feedback system that controls energy homeostasis must be responding to different inputs than in the past. In this review we discuss the influence of gender on the efficacy of adiposity hormones as they interact with food intake control systems in the brain. Specifically, the levels of insulin and leptin in the blood are correlated with body fat, insulin being related mainly to visceral fat and ieptin to subcutaneous fat. Since females carry more fat subcutaneously and males carry more fat viscerally, leptin correlates better with total body fat in females and insulin correlates better in males. High visceral fat and plasma insulin are also risk factors for the complications of obesity, including type-2 diabetes, cardiovascular problems, and certain cancers, and these are more prevalent in males. Consistent with these systemic differences, the brains of females are more sensitive to the catabolic actions of low doses of leptin whereas the brains of males are more sensitive to the catabolic action of low doses of insulin. The implications of this are discussed.
FlegalKM, CarrollMD, OgdenCL, JohnsonCL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA288: 1723–1727, 2002.
2.
PopkinBM, PaeratakulS, ZhaiF, GeK.Dietary and environmental correlates of obesity in a population study in China. Obes Res3:(Suppl):135S–143S, 1995.
3.
PopkinBM, DoakC.The obesity epidemic is a worldwide phenomenon. Nutr Rev56: 106–114, 1998.
4.
OgdenCL, FlegalKM, CarrollMD, JohnsonCL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA288: 1728–1732, 2002.
5.
Health and Human Services.The Surgeon General's Call to Action To Prevent and Decrease Overweight and Obesity. In: U.S. Public Health Service, Office of the Surgeon General, Washington, D.C., 2001.
6.
McNuttSW, HuY, SchreiberGB, CrawfordPB, ObarzanekE, MellinL.A longitudinal study of the dietary practices of black and white girls 9 and 10 years old at enrollment: the NHLBI Growth and Health Study. J Adolesc Health20: 27–37, 1997.
7.
CummingsDE, SchwartzMW. Genetics and pathophysiology of human obesity. Ann Rev Med54: 453–471, 2003.
8.
EckelRH, BarouchWW, ErshowAG. Report of the National Heart Lung and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation105: 2923–2928, 2002.
9.
World Health Organization Obesity.Preventing and managing the global epidemic. In: World Health Organization, Geneva, 1998
10.
KeeseyRE, HirvonenMD. Body weight set-points: determination and adjustment. J Nutr127: 1875S–1883S, 1997.
11.
SchwartzMW, WoodsSC, PorteDJ, SeeleyRJ, BaskinDG. Central nervous system control of food intake. Nature404: 661–671, 2000.
12.
WoodsSC, SeeleyRJ. Adiposity signals and the control of energy homeostasis. Nutrition16: 894–902, 2000.
13.
WoodsSC, SeeleyRJ, PorteDJ, SchwartzMW. Signals that regulate food intake and energy homeostasis. Science280: 1378–1383, 1998.
14.
PinelJPJ, AssanandS, LehmanDR. Hunger, eating and ill health. Am Psychol55: 1105–1116, 2000.
15.
WoodsSC. The eating paradox: How we tolerate food. Psychol Rev98: 488–505, 1991.
16.
WoodsSC, StrubbeJH. The psychobiology of meals. Psychonomic Bulletin and Review1: 141–155, 1994.
17.
StrubbeJH, WoodsSC. The timing of meals. Psychol Rev. (in press).
18.
KennedyGC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond140: 579–592, 1953.
19.
AhimaRS, SaperCB, FlierJS, ElmquistJK. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol21: 263–307, 2000.
20.
ElmquistJK, EliasCF, SaperCB. From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron22: 221–232, 1999.
WoodsSC, SchwartzMW, BaskinDG, SeeleyRJ. Food intake and the regulation of body weight. Annu Rev Psychol51: 255–277, 2000.
23.
BanksWA, KastinAJ, HuangW.Leptin enters the brain by a saturable system independent of insulin. Peptides17: 305–311, 1996.
24.
BanksWA, JaspanJB, KastinAJ. Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides18: 1577–1584, 1997.
25.
BanksWA, DiPalmaCR, FarrellCL. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides20: 1341–1345, 1999.
26.
BauraG, FosterD, PorteD, Jr KahnSE, BergmanRN, CobelliC, SchwartzMW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: a mechanism for regulated insulin delivery to the brain. J Clin Invest92: 1824–1830, 1993.
27.
BauraGD. Quantitation of central nervous system uptake and its regulation by steroids and obesity. In: Doctoral Dissertation. University of Washington Press1993.
28.
SchwartzMW, SipolsAJ, KahnSE, LattemannDP, TaborskyGJ, Jr BergmanRN, WoodsSC, PorteD.Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol259: E378–E383, 1990.
29.
ConeRD, CowleyMA, ButlerAA, FanW, MarksDL, LowMJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord25:(Suppl 5):S63–S67, 2001.
30.
WoodsSC, FiglewiczDP, MaddenL, PorteJD, SipolsAJ, SeeleyRJ. NPY and food intake: Discrepancies in the model. Regul Peptides75–76: 403–408, 1998.
31.
McMinnJE, WilkinsonCW, HavelPJ, WoodsSC, SchwartzMW. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am J Physiol279: R695–R703, 2000.
BenoitSC, AirEL, CoolenLM, StraussR, JackmanA, CleggDJ, SeeleyRJ, WoodsSC. The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci22: 9048–9052, 2002.
34.
BarshGS, FarooqiIS, O'rahillyS.Genetics of body-weight regulation. Nature404: 644–651, 2000.
35.
ComuzzieAG, HixsonJE, AlmasyL, MitchellBD, MahaneyMC, DyerTD, SternMP, MacCluerJW, BlangeroJ.A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet15: 273–276, 1997.
36.
CampfieldLA, SmithFJ, GulsezY, DevosR.Burn P. Mouse OB Protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science269: 546–549, 1995.
37.
SipolsAJ, BaskinDG, SchwartzMW. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes44: 147–151, 1995.
38.
NiswenderKD, SchwartzMW. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol24: 1–10, 2003.
39.
PorteDJ, BaskinDG, SchwartzMW. Leptin and insulin action in the central nervous system. Nutr Rev60: S20–S29, 2003.
40.
BillingtonCJ, BriggsJE, GraceM, LevineAS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol260: R321–R327, 1991.
41.
ClarkJT, KalraPS, CrowleyWR, KalraSP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology115: 427–429, 1984.
42.
StanleyBG, LeibowitzSF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sciences35: 2635–2642, 1984.
43.
BaskinDG, BreiningerJF, SchwartzMW. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes48: 828–833, 1999.
44.
SchwartzMW, MarksJ, SipolsAJ, BaskinDG, WoodsSC, KahnSE, PorteDJr.Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology128: 2645–2647, 1991.
45.
ConeRD, LuD, KoppulaS, VageDI, KlunglandH, BostonB, ChenW, OrthDN, PoutonC, KestersonRA. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res51: 287–320, 1996.
46.
ConeRD. The Central Melanocortin System and Energy Homeostasis. Trends Endocrinol Metab10: 211–216, 1999.
47.
ConeRD Ed. The Melanocortin Receptors. New Jersey, Humana Press, 2000.
48.
HaganMM, RushingPA, PritchardLM, SchwartzMW, StrackAM, Van der PloegHT, WoodsSC, SeeleyRJ. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol279: R47–R52, 2000.
49.
HaganMM, BenoitSC, RushingPA, PritchardLM, WoodsSC, SeeleyRJ. Immediate and prolonged patterns of agouti-related peptide-(83-132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites. Endocrinology142: 1050–1056, 2001.
50.
MontagueCT, FarooqiIS, WhiteheadJP, SoosMA, RauH, WarehamNJ, SewterCP, DigbyJE, MohammedSN, HurstJA, CheethamCH, EarleyAR, BarnettAH, PrinsJB, O'rahillyS.Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature387: 903–908, 1997.
51.
CasabiellX, PineiroV, PeinoR, LageM, CaminaJ, GallegoR, VallejoLG, DieguezC, CasanuevaFF. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab83: 2149–2155, 1998.
52.
DemerathEW, TowneB, WisemandleW, BlangeroJ, ChumleaWC, SiervogelRM. Serum leptin concentration, body composition, and gonadal hormones during puberty. Int J Obes Relat Metab Disord23: 678–685, 1999.
53.
RosenbaumM, NicolsonM, HirschJ, HeymsfieldSB, GallagherD, ChuF, LeibelRL. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab81: 3424–3427, 1996.
54.
FrederichRC, HamannA, AndersonS, LollmannB, LowellBB, FlierJS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med1: 1311–1314, 1995.
55.
CleggDJ, RiedyCA, SmithKA, BenoitSC, WoodsSC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes52: 682–687, 2003.
56.
OstlundREJr., YangJW, KleinS, GingerichR.Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab81: 3909–3913, 1996.
57.
KennedyA, GettysTW, WatsonP, WallaceP, GanawayE, PanQ, GarveyWT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab82: 1293–1300, 1997.
DuaA, HennesMI, HoffmanRG, MaasDL, KrakowerGR, SonnenbergGE, KissebahAH. Leptin: A significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes45: 1635–1637, 1996.
HavelPJ, KasimKarakasS, MuellerW, JohnsonPR, GingerichRL, SternJS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab81: 4406–4413, 1996.
65.
LegatoMJ. Gender-specific aspects of obesity. Int J Fertil Womens Med42: 184–197, 1997.
66.
KotaniK, TokunagaK, FujiokaS, KobatakeT, KenoY, YoshidaS, ShimomuraI, TaruiS, MatsuzawaY.Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord18: 207–212, 1994.
67.
WajchenbergBL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev21: 697–738, 2000.
68.
DespresJP. The insulin-resistance-dyslipidemic syndrome of visceral obesity: Effect on patients' risk. Obesity Research6:(Suppl 1):8S–17S, 1998.
69.
LamarcheB.Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease. Coron Artery Dis9: 473–481, 1998.
70.
MarinP, AnderssonB, OttossonM, OlbeL, ChowdhuryB, KvistH, HolmG, SjostromL, BjorntorpP.The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism41: 1242–1248, 1992.
71.
MarinP, HolmangS, JonssonL, SjostromL, KvistH, HolmG, LindstedtG, BjorntorpP.The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord16: 991–997, 1992.
72.
BolinderJ, OstmanJ, ArnerP.Influence of aging on insulin receptor binding and metabolic effects of insulin on human adipose tissue. Diabetes32: 959–964, 1983.
73.
BolinderJ, EngfeldtP, OstmanJ, ArnerP.Site differences in insulin receptor binding and insulin action in subcutaneous fat of obese females. J Clin Endocrinol Metab57: 455–461, 1983.
74.
CareyDG, JenkinsAB, CampbellLV, FreundJ, ChisholmDJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes45: 633–638, 1996.
75.
O'shaughnessyIM, MyersTJ, StepniakowskiK, NazzaroP, KellyTM, HoffmannRG, EganBM, KissebahAH. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension26: 186–192, 1995.
76.
ColombelA, CharbonnelB.Weight gain and cardiovascular risk factors in the post-menopausal women. Hum Reprod12: 134–145, 1997.
77.
BjorkelundC, LissnerL, AnderssonS, LapidusL, BengtssonC.Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord20: 213–219, 1996.
78.
GambaccianiM, CiaponiM, CeppagliB, PiaggesiL, De SimoneL, OrlandiR, GenazzaniAR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab82: 414–417, 1997.
HaarboJ, MarslewU, GotfredsenA, ChristiansenC.Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism40: 1323–1326, 1991.
81.
BouchardC, DespresJP, MauriegeP.Genetic and nongenetic determinants of regional fat distribution. Endocr Rev14: 72–93, 1993.
82.
TchernofA, Calles-EscandonJ, SitesCK, PoehlmanET. Menopause, central body fatness, and insulin resistance: Effects of hormone-replacement therapy. Coron Artery Dis9: 503–511, 1998.
83.
HillJO, WyattHR, ReedGW, PetersJC. Obesity and the environment: where do we go from here?Science299: 853–855, 2003.
84.
GotohK, SeeleyRJ, D'alessioDA, TsoP, WoodsSC. High-fat diet prevents the anorectic effect of central insulin. In: SchwartzMW, CollinsS, BarshGS Eds. Keystone Symposium: Obesity, New Insights into Pathogenesis and Treatment, p 136, 2003.
85.
WoodsSC, SeeleyRJ, RushingPA, D'alessioDA, TsoP.A controlled high-fat diet induces an obese syndrome in rats. J Nutr133: 1081–1087, 2003.
